HealthEquity’s credit outlook raised to positive by Moody’s

Published 27/08/2025, 19:58
© Reuters.

Investing.com -- Moody’s Ratings has affirmed HealthEquity, Inc.’s corporate family rating at Ba3 while changing the outlook from stable to positive, citing improved credit metrics following the successful integration of the BenefitWallet acquisition.

The rating agency maintained the company’s probability of default rating at Ba3-PD and affirmed the $600 million senior unsecured notes rating at B1. HealthEquity’s speculative grade liquidity rating remains unchanged at SGL-1.

The positive outlook reflects HealthEquity’s increased scale, improved free cash flow generation, and reduced financial leverage. The company’s debt-to-EBITDA ratio (less capitalized software costs) stands at 3.4x for the 12-month period ended April 30, 2025.

As the largest non-bank custodian of Health Savings Accounts in the US, HealthEquity has strengthened its competitive position following the BenefitWallet acquisition. The company generated approximately $300 million in free cash flow (26% of debt) for the period ended April 30, 2025, with strong EBITDA margins in the high 20s to low 30s percent range.

Moody’s noted that HealthEquity’s modest revenue scale of approximately $1.2 billion remains below other similarly rated service providers. The company’s financial policies include using debt to fund acquisitions as a growth strategy, which impacts its rating.

The rating agency expects mid to high-single digit organic revenue growth and approximately $300 million in free cash flow going forward. HealthEquity had about $288 million in cash as of April 30, 2025, with an expected $550 million remaining available under its $1 billion revolving credit facility.

Moody’s indicated that ratings could be upgraded if HealthEquity further expands its revenue scale while maintaining EBITDA margins above 30% and debt-to-EBITDA below 4.0x. Conversely, ratings could be downgraded if revenue growth slows, the company loses significant market share, or if debt-to-EBITDA exceeds 5.0x.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.